Table 2 The fivefold cross validation results of the proposed network
Fold 1 | Fold 2 | Fold 3 | Fold 4 | Fold 5 | |
|---|---|---|---|---|---|
Number of patients (benign/malignant) | 669 (376/293) | 669 (376/293) | 671 (376/295) | 669 (376/293) | 674 (378/296) |
Number of lesions (benign/malignant) | 2986 (1505/1481) | 2952 (1389/1563) | 3084 (1468/1616) | 2897 (1475/1422) | 3053 (1465/1588) |
Sensitivity | 83.19 | 83.11 | 79.89 | 76.79 | 83.5 |
Specificity | 78.07 | 82.58 | 82.7 | 82.78 | 79.59 |
Accuracy | 80.61 | 82.86 | 81.23 | 79.84 | 81.62 |
PPV | 78.87 | 84.3 | 83.56 | 81.13 | 81.6 |
NPV | 82.51 | 81.29 | 78.88 | 78.72 | 81.65 |